Average rating: | Rated 3.5 of 5. |
Level of importance: | Rated 3 of 5. |
Level of validity: | Rated 4 of 5. |
Level of completeness: | Rated 3 of 5. |
Level of comprehensibility: | Rated 4 of 5. |
Competing interests: | None |
Thank you for inviting me to review this manuscript.
This study develops a comprehensive score to assess Guillain-Barre Syndrome (GBS) severity and applies this score to case reports describing GBS from SARS-CoV-2 and non-SARS-CoV-2 causes. In general, the overall findings are of interest, as they indicate that GBS is no more severe when caused by SARS-CoV-2, which may have implications for the clinical management of this disease. Points to consider in a revised manuscript are included below: